Table 2.

Outcomes at different time points in follow‐up

	Baseline n = 131	8 weeks n = 131	24 weeks n = 117	52 weeks n = 76
Steroid‐free remission; n (%)	—	46 (35)	47 (40)	33 (43)
Response; n (%)	—	76 (58)	75 (64)	45 (59)
CRP positive; n (%)	70 (53)	56 (43)	45 (38)	15 (25)
AEs overall; n (%)	—	7 (5)	12 (10)	2 (3)
Discontinuation of treatment (overall); n (%)	—	3 (2)	11 (9)	1 (1.3)
Primary failure		1 (1)	4 (3)	0
Secondary failure		0	7 (6)	1 (1.3)
AEs		2 (1.5)	0	0
Surgery; n (%)§	—	3 (3)	3 (2.5)	0

§Surgery for perianal disease included, analysis intention‐to‐treat.

Numbers are expressed as crude numbers and percentages.

CRP, C‐reactive protein; AEs, adverse events.